A carregar...
Evidence-based review and appraisal of the use of droperidol in the emergency department
Droperidol is a short-acting, potent dopamine D2 antagonist that can pass through the blood–brain barrier. A black box warning was issued for droperidol by the United States Food and Drug Administration in 2001 because of a risk of development of torsades de pointes induced by QT prolongation. Many...
Na minha lista:
| Publicado no: | Tzu Chi Med J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5883829/ https://ncbi.nlm.nih.gov/pubmed/29643708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tcmj.tcmj_195_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|